Nilai Bisnis: sonnetbio.com (SONN)

Sonnet BioTherapeutics (SONN) relies on patent protection for unique protein modification methods, guaranteeing its leadership status in high-cost medical niches. The business focuses on R&D development and the creation of extended-release drug delivery systems for combating tumors. The current market quotes illustrated below, with an Enterprise Value of 8.67, confirm growth potential driven by successful clinical trials and future contracts with pharma behemoths.

Sonnet BioTherapeutics Holdings (SONN) - Nilai Total Perusahaan saka 23.11.2025 nganti 13.12.2025

Sonnet BioTherapeutics Holdings (SONN) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Sonnet BioTherapeutics Holdings, Inc.|SONN - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Sonnet BioTherapeutics|SONN - Nilai Total Perusahaan

- indikator nilai aset resik miturut neraca:

Ekuitas saben Saham Sonnet BioTherapeutics|SONN - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku sonnetbio.com|SONN - Aset Agregat Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Sonnet BioTherapeutics|SONN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Sonnet BioTherapeutics Holdings, Inc.|SONN - Utang perusahaan|Utang-utang marang nilai buku Sonnet BioTherapeutics|SONN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sonnet BioTherapeutics|Likuiditas darurat sonnetbio.com

- indikator bathi lan kelipatan valuasi:

SONN - Bathi resik

Analisis kabeh metrik perusahaan:Sonnet BioTherapeutics

Barang unggulan Sonnet BioTherapeutics Holdings Inc.

Enterprise value determines the actual buyout price of a business, accounting for debt load and liquid assets. The formula sums market capitalization with liabilities, subtracting cash to identify the net financial leverage. The trend of total capitalization including debt reflects the company's sensitivity to market cycles. For Sonnet BioTherapeutics (SONN), this indicator is critical due to high R&D expenditures. Investments in the FHAB platform directly impact asset value.

Pesaing Sonnet BioTherapeutics (SONN)

ImmunityBio Inc (IBRX) - Total Nilai Perusahaan|IMCR - Nilai Total Perusahaan|JANX (Janux Corp) - Nilai Bisnis|Arcus Biosciences, Inc. (RCUS) - Nilai Total Perusahaan|Nilai Bisnis ZYME|Nilai Total Perusahaan Tango Therapeutics, Inc.|Total Nilai Perusahaan Iovance Biotherapeutics Inc IOVA|Nilai Total Perusahaan Immatics Corp (IMTX)|Xencor Inc. - Nilai Bisnis|Nilai Perusahaan CMPX (Compass Therapeutics)|REPL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|LYEL - Nilai Total Perusahaan|Total Nilai Perusahaan Innate Pharma SA|pyxisoncology.com (PYXS) - Nilai Total Perusahaan|CGEN (Compugen) - Nilai Total Perusahaan|Nilai Total Perusahaan IO Biotech, Inc.|Total Nilai Perusahaan sutrobio.com STRO|Nilai Perusahaan INKT|werewolftx.com (HOWL) - Nilai Perusahaan Nalika Diakuisisi Penuh|Immix Biopharma - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ALX Oncology Holdings Inc. (ALXO) - Total Nilai Perusahaan|CUE: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas PDSB (PDS Biotechnology)|MAIA: Nilai Perusahaan|LIMN - Rega Tumbas Perusahaan|Nilai Total Perusahaan LAVA Therapeutics NV|Rega Nyata Tumbas Perusahaan Kanthi Wutuh NextCure Corporation (NXTC)|Nilai Total Perusahaan Leap Therapeutics, Inc. (LPTX)|Rega Nyata Tumbas Perusahaan Kanthi Wutuh intensitytherapeutics.com INTS|Sensei Biotherapeutics, Inc. - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Theriva Biologics Inc TOVX|GRTS - Nilai Total Perusahaan|KA (Kineta Corp) - Nilai Bisnis|NexImmune, Inc. (NEXI) - Nilai Total Perusahaan|Total Nilai Perusahaan Turnstone Biologics Corp. (TSBX)|Rega Nyata Tumbas Perusahaan Kanthi Wutuh VCNX|HARP - Nilai Perusahaan Nalika Diakuisisi Penuh